#AskDrDurie: What should we know about the FDA approval of ixazomib (Ninlaro)? (https://www.myeloma.org/videos/askdrdurie-should-we-know-about-fda-approval-ixazomib-ninlaror)
In this week's video, Dr. Brian G.M. Durie discusses the recently FDA approved drug ixazomib (Ninlaro®).
Bottom Line:
Ninlaro is an important addition to the lineup of myeloma treatments.
Old Id
542
Ask a Question
Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).
Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.